Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer
The goals of drug repositioning are to find a new pharmacological effect of a drug for which human safety and pharmacokinetics are established and to expand the therapeutic range of the drug to another disease. Such drug discovery can be performed at low cost and in the short term based on the resul...
Saved in:
Main Authors: | Kouji Banno, Miho Iida, Megumi Yanokura, Haruko Irie, Kenta Masuda, Yusuke Kobayashi, Eiichiro Tominaga, Daisuke Aoki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2015/341362 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
by: Kouji Banno, et al.
Published: (2014-01-01) -
Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics
by: Kouji Banno, et al.
Published: (2012-01-01) -
Graft-repositioning technique using infusion and small bubbles during Descemet’s membrane endothelial keratoplasty
by: Toshiki Shimizu, et al.
Published: (2025-01-01) -
Improving drug repositioning with negative data labeling using large language models
by: Milan Picard, et al.
Published: (2025-02-01) -
Nucleosome repositioning in cardiac reprogramming
by: Sonalí Harris, et al.
Published: (2025-01-01)